Disclosures for "Binding Characteristics of PRX012 Surrogate Demonstrate Potent Engagement of Toxic Amyloid Beta Protofibrils and Robust Clearance of Pyroglutamate-modified Amyloid Beta"
-
Dr. Campbell has received personal compensation for serving as an employee of Prothena Biosciences. Dr. Campbell has received personal compensation in the range of $0-$499 for serving as a Consultant for MindImmune Therapeutics. Dr. Campbell has stock in Prothena Biosciences. Dr. Campbell has stock in MindImmune Therapeutics.
-
Dr. Zhang has received personal compensation for serving as an employee of Prothena Biosciences.
-
Mr. Salmans has received personal compensation for serving as an employee of Prothena Biosciences.
-
Dr. Elmaarouf has received personal compensation for serving as an employee of Prothena Bioecience. Dr. Elmaarouf has stock in Prothena Bioscience.
-
Mr. Tam has received personal compensation for serving as an employee of Prothena. Mr. Tam has received intellectual property interests from a discovery or technology relating to health care. Mr. Tam has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Porat has nothing to disclose.
-
Mr. Skov has received personal compensation for serving as an employee of Prothena Biosciences Inc.
-
Dr. Dolan has received personal compensation for serving as an employee of Prothena Biosciences. Dr. Dolan has stock in Prothena Biosciences. Dr. Dolan has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Kinney has received personal compensation for serving as an employee of Prothena. Dr. Kinney has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Prothena. Dr. Kinney has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Libra Therapeutics. Dr. Kinney has stock in Prothena. Dr. Kinney has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Zago has received personal compensation for serving as an employee of Prothena . Dr. Zago has received stock or an ownership interest from Prothena.